Literature DB >> 2318081

Multiparametric analysis of cell membrane permeability by two colour flow cytometry with complementary fluorescent probes.

C Dive1, J V Watson, P Workman.   

Abstract

We describe an improved twin-probe multiparameter flow cytometric technique to examine cell membrane permeability. Ability to retain preloaded intracellular bis-carboxyethyl carboxy fluorescein (BCECF, green fluorescence) and to exclude extracellular propidium (red fluorescence) is measured, simultaneously with forward and right-angle scatter. This has significant advantages over an earlier method using fluorescein together with ethidium. In addition to the two expected cell populations which were stained green positive, red negative (by convention membrane "intact" and "viable," Region 1) and green negative, red positive ("membrane-damaged" and "non-viable," Region 3), a third population was seen which fluoresced neither green nor red and displayed intermediate light scatter characteristics (Region 2). This was true for each of 9 cell types in vitro. For EMT6 mouse mammary tumour cells held under sub-optimal conditions or treated with membrane-active drugs, progression from Region 1 to Region 2 was observed, followed by further progression from Region 2 to Region 3. Cells eventually accumulated in Region 3. These results suggest that sequential changes in membrane structure lead to increased permeability, first with respect to intracellular BCECF and in turn to extracellular propidium.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2318081     DOI: 10.1002/cyto.990110205

Source DB:  PubMed          Journal:  Cytometry        ISSN: 0196-4763


  9 in total

1.  Optical recording of intracellular pH in respiratory chemoreceptors.

Authors:  Matthew J Gdovin; Debora A Zamora; C R Marutha Ravindran; James C Leiter
Journal:  Ethn Dis       Date:  2010       Impact factor: 1.847

2.  Bile salts: natural detergents for the prevention of sexually transmitted diseases.

Authors:  B C Herold; R Kirkpatrick; D Marcellino; A Travelstead; V Pilipenko; H Krasa; J Bremer; L J Dong; M D Cooper
Journal:  Antimicrob Agents Chemother       Date:  1999-04       Impact factor: 5.191

3.  Detection of multidrug resistance and quantification of responses of human tumour cells to cytotoxic agents using flow cytometric spectral shift analysis of Hoechst 33,342-DNA fluorescence.

Authors:  P J Smith; S A Morgan; J V Watson
Journal:  Cancer Chemother Pharmacol       Date:  1991       Impact factor: 3.333

4.  Probing enzymatic activity inside living cells using a nanowire-cell "sandwich" assay.

Authors:  Yu-Ran Na; So Yeon Kim; Jellert T Gaublomme; Alex K Shalek; Marsela Jorgolli; Hongkun Park; Eun Gyeong Yang
Journal:  Nano Lett       Date:  2012-12-20       Impact factor: 11.189

5.  Alloxan cytotoxicity is highly potentiated by plasma membrane- and lysosomal-associated iron--a study on a model system of cultured J-774 cells.

Authors:  H Zhang; U T Brunk
Journal:  Diabetologia       Date:  1993-08       Impact factor: 10.122

6.  Cytotoxicity anticancer activities of anastrozole against breast, liver hepatocellular, and prostate cancer cells.

Authors:  Firas Hassan; Gamal A El-Hiti; Mays Abd-Allateef; Emad Yousif
Journal:  Saudi Med J       Date:  2017-04       Impact factor: 1.484

7.  Tumor treating fields increases membrane permeability in glioblastoma cells.

Authors:  Edwin Chang; Chirag B Patel; Christoph Pohling; Caroline Young; Jonathan Song; Thomas Anthony Flores; Yitian Zeng; Lydia-Marie Joubert; Hamed Arami; Arutselvan Natarajan; Robert Sinclair; Sanjiv S Gambhir
Journal:  Cell Death Discov       Date:  2018-12-05

8.  Kinetics of MDR transport in tumor-initiating cells.

Authors:  Vasilij Koshkin; Burton B Yang; Sergey N Krylov
Journal:  PLoS One       Date:  2013-11-01       Impact factor: 3.240

9.  DNA Intercalators Inhibit Eukaryotic Ribosomal RNA Synthesis by Impairing the Initiation of Transcription.

Authors:  William J Andrews; Swagat Ray; Tatiana Panova; Christoph Engel; Konstantin I Panov
Journal:  Genes (Basel)       Date:  2021-09-14       Impact factor: 4.096

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.